LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | LDN-193189 | 0.04 | uM | LJP5 | 72 | hr | 1097 | 3807 | 3769 | 1.0099 | 1.0140 |
BT-20 | Nilotinib | 3.33 | uM | LJP5 | 72 | hr | 1097 | 3734 | 3769 | 0.9907 | 0.9868 |
BT-20 | Dactolisib | 3.33 | uM | LJP5 | 72 | hr | 1097 | 1295 | 3769 | 0.3435 | 0.0740 |
BT-20 | WH-4-025 | 0.37 | uM | LJP5 | 72 | hr | 1097 | 2814 | 3769 | 0.7467 | 0.6427 |
BT-20 | SB590885 | 0.04 | uM | LJP5 | 72 | hr | 1097 | 3918 | 3769 | 1.0395 | 1.0557 |
BT-20 | XMD16-144 | 0.37 | uM | LJP5 | 72 | hr | 1097 | 1323 | 3769 | 0.3512 | 0.0847 |
BT-20 | Brivanib | 0.37 | uM | LJP5 | 72 | hr | 1097 | 3699 | 3769 | 0.9813 | 0.9736 |
BT-20 | Buparlisib | 0.37 | uM | LJP5 | 72 | hr | 1097 | 1950 | 3769 | 0.5175 | 0.3194 |
BT-20 | BX-912 | 0.37 | uM | LJP5 | 72 | hr | 1097 | 3616 | 3769 | 0.9594 | 0.9427 |
BT-20 | NVP-AEW541 | 0.12 | uM | LJP5 | 72 | hr | 1097 | 3912 | 3769 | 1.0378 | 1.0533 |
BT-20 | SB590885 | 0.12 | uM | LJP5 | 72 | hr | 1097 | 3896 | 3769 | 1.0337 | 1.0476 |
BT-20 | CGP60474 | 0.37 | uM | LJP5 | 72 | hr | 1097 | 716 | 3769 | 0.1900 | -0.1426 |
BT-20 | PIK-93 | 0.12 | uM | LJP5 | 72 | hr | 1097 | 4017 | 3769 | 1.0656 | 1.0926 |
BT-20 | LDN-193189 | 0.37 | uM | LJP5 | 72 | hr | 1097 | 3201 | 3769 | 0.8493 | 0.7874 |
BT-20 | CP724714 | 0.37 | uM | LJP5 | 72 | hr | 1097 | 3643 | 3769 | 0.9665 | 0.9528 |
BT-20 | CP466722 | 0.37 | uM | LJP5 | 72 | hr | 1097 | 3786 | 3769 | 1.0044 | 1.0062 |
BT-20 | Crizotinib | 0.37 | uM | LJP5 | 72 | hr | 1097 | 3267 | 3769 | 0.8668 | 0.8121 |
BT-20 | Momelotinib | 0.37 | uM | LJP5 | 72 | hr | 1097 | 3474 | 3769 | 0.9216 | 0.8894 |
BT-20 | Dasatinib | 0.37 | uM | LJP5 | 72 | hr | 1097 | 1463 | 3769 | 0.3881 | 0.1369 |
BT-20 | Luminespib | 0.12 | uM | LJP5 | 72 | hr | 1097 | 1164 | 3769 | 0.3090 | 0.0252 |
BT-20 | Dovitinib | 0.37 | uM | LJP5 | 72 | hr | 1097 | 1624 | 3769 | 0.4310 | 0.1974 |
BT-20 | Enzastaurin | 0.37 | uM | LJP5 | 72 | hr | 1097 | 4103 | 3769 | 1.0886 | 1.1249 |
BT-20 | Erlotinib | 0.37 | uM | LJP5 | 72 | hr | 1097 | 3329 | 3769 | 0.8832 | 0.8353 |
BT-20 | Foretinib | 0.37 | uM | LJP5 | 72 | hr | 1097 | 1634 | 3769 | 0.4335 | 0.2009 |
BT-20 | PLX-4720 | 3.33 | uM | LJP5 | 72 | hr | 1097 | 2550 | 3769 | 0.6767 | 0.5439 |